Edgewell Personal Care (EPC)
Market Price (8/9/2026): $28.375 | Market Cap: $1.3 BilSector: Consumer Staples | Industry: Household Products
Edgewell Personal Care (EPC)
Market Price (8/9/2026): $28.375Market Cap: $1.3 BilSector: Consumer StaplesIndustry: Household Products
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 12% Attractive yieldDividend Yield is 2.2% Low stock price volatilityVol 12M is 42% Megatrend and thematic driversMegatrends include Health & Wellness Trends, E-commerce & Digital Retail, and Circular Economy & Recycling. Themes include Personal Grooming & Hygiene, Show more. | Trading close to highsDist 52W High is -4.3% Weak multi-year price returns2Y Excs Rtn is -69%, 3Y Excs Rtn is -96% Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 10% | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 67% Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 38x Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.3% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -6.5% Key risksEPC key risks include [1] persistent underperformance and market share loss in its core North American wet shave market, Show more. |
| Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 12% |
| Attractive yieldDividend Yield is 2.2% |
| Low stock price volatilityVol 12M is 42% |
| Megatrend and thematic driversMegatrends include Health & Wellness Trends, E-commerce & Digital Retail, and Circular Economy & Recycling. Themes include Personal Grooming & Hygiene, Show more. |
| Trading close to highsDist 52W High is -4.3% |
| Weak multi-year price returns2Y Excs Rtn is -69%, 3Y Excs Rtn is -96% |
| Meaningful short interestShort Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 10% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 67% |
| Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 38x |
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.3% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -6.5% |
| Key risksEPC key risks include [1] persistent underperformance and market share loss in its core North American wet shave market, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Edgewell Personal Care (EPC) stock has gained about 25% since 4/30/2026 because of the following key factors:
1. Edgewell Personal Care (EPC) exceeded expectations with its fiscal Q2 2026 earnings, reported on May 6, 2026. The company's adjusted earnings per share (EPS) of $0.60 significantly beat analysts' consensus estimates of $0.43 by $0.17. Additionally, quarterly revenue of $519.50 million surpassed the consensus estimate of $518.51 million, marking a 0.6% year-over-year increase.
2. Multiple analyst firms raised their price targets for Edgewell Personal Care during the period. On July 8, 2026, Wells Fargo & Company increased its price target from $24.00 to $30.00, assigning an "overweight" rating. Canaccord Genuity Group also boosted its price objective from $32.00 to $34.00 with a "buy" rating on July 7, 2026. By July 31, 2026, the average one-year price target was adjusted to $28.56 per share, representing a 14.29% increase from the prior estimate of $24.99.
Show more
Edgewell Personal Care (EPC) stock has gained about 25% since 4/30/2026 because of the following key factors:
1. Edgewell Personal Care (EPC) exceeded expectations with its fiscal Q2 2026 earnings, reported on May 6, 2026. The company's adjusted earnings per share (EPS) of $0.60 significantly beat analysts' consensus estimates of $0.43 by $0.17. Additionally, quarterly revenue of $519.50 million surpassed the consensus estimate of $518.51 million, marking a 0.6% year-over-year increase.
2. Multiple analyst firms raised their price targets for Edgewell Personal Care during the period. On July 8, 2026, Wells Fargo & Company increased its price target from $24.00 to $30.00, assigning an "overweight" rating. Canaccord Genuity Group also boosted its price objective from $32.00 to $34.00 with a "buy" rating on July 7, 2026. By July 31, 2026, the average one-year price target was adjusted to $28.56 per share, representing a 14.29% increase from the prior estimate of $24.99.
3. The company demonstrated a return to organic net sales growth in fiscal Q3 2026, which ended June 30, 2026, and reaffirmed its full-year outlook. On August 5, 2026, Edgewell reported fiscal Q3 2026 adjusted EPS of $0.72, exceeding the analyst consensus of $0.63 by $0.09. Organic net sales increased by 1.1% year-over-year, driven primarily by a 3.0% increase in North America across Sun Care, Skin Care, and Grooming categories. Management also maintained its midpoint for the full-year fiscal 2026 adjusted EPS guidance, which slightly exceeded the analyst consensus.
4. Edgewell Personal Care improved its cash position and reduced interest expenses, partly driven by the divestiture of its Feminine Care business. The company's cash on hand increased to $397.1 million by the end of fiscal Q3 2026 (June 30, 2026), up from $225.7 million as of September 30, 2025. This increase included $338.9 million in proceeds from a business sale. Furthermore, the company reported lower interest expense, which fell to $16.7 million from $19.4 million year-over-year in fiscal Q3 2026, attributed to reduced revolving-credit borrowings following the Feminine Care divestiture.
Show less
Stock Movement Drivers
Fundamental Drivers
The 26.8% change in EPC stock from 4/30/2026 to 8/8/2026 was primarily driven by a 24.7% change in the company's P/S Multiple.| (LTM values as of) | 4302026 | 8082026 | Change |
|---|---|---|---|
| Stock Price ($) | 22.39 | 28.38 | 26.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 2,231 | 2,244 | 0.6% |
| P/S Multiple | 0.5 | 0.6 | 24.7% |
| Shares Outstanding (Mil) | 47 | 46 | 1.1% |
| Cumulative Contribution | 26.8% |
Market Drivers
4/30/2026 to 8/8/2026| Return | Correlation | |
|---|---|---|
| EPC | 26.8% | |
| Market (SPY) | 7.6% | -12.7% |
| Sector (XLP) | 1.0% | 40.6% |
Fundamental Drivers
The 48.0% change in EPC stock from 1/31/2026 to 8/8/2026 was primarily driven by a 45.0% change in the company's P/S Multiple.| (LTM values as of) | 1312026 | 8082026 | Change |
|---|---|---|---|
| Stock Price ($) | 19.18 | 28.38 | 48.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 2,224 | 2,244 | 0.9% |
| P/S Multiple | 0.4 | 0.6 | 45.0% |
| Shares Outstanding (Mil) | 47 | 46 | 1.1% |
| Cumulative Contribution | 48.0% |
Market Drivers
1/31/2026 to 8/8/2026| Return | Correlation | |
|---|---|---|
| EPC | 48.0% | |
| Market (SPY) | 12.1% | 0.4% |
| Sector (XLP) | 2.5% | 45.5% |
Fundamental Drivers
The 15.8% change in EPC stock from 7/31/2025 to 8/8/2026 was primarily driven by a 7.0% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 7312025 | 8082026 | Change |
|---|---|---|---|
| Stock Price ($) | 24.50 | 28.38 | 15.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 2,097 | 2,244 | 7.0% |
| P/S Multiple | 0.6 | 0.6 | 4.0% |
| Shares Outstanding (Mil) | 48 | 46 | 4.1% |
| Cumulative Contribution | 15.8% |
Market Drivers
7/31/2025 to 8/8/2026| Return | Correlation | |
|---|---|---|
| EPC | 15.8% | |
| Market (SPY) | 23.4% | 7.4% |
| Sector (XLP) | 8.9% | 43.3% |
Fundamental Drivers
The -23.3% change in EPC stock from 7/31/2023 to 8/8/2026 was primarily driven by a -31.7% change in the company's P/S Multiple.| (LTM values as of) | 7312023 | 8082026 | Change |
|---|---|---|---|
| Stock Price ($) | 36.98 | 28.38 | -23.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 2,228 | 2,244 | 0.7% |
| P/S Multiple | 0.9 | 0.6 | -31.7% |
| Shares Outstanding (Mil) | 51 | 46 | 11.5% |
| Cumulative Contribution | -23.3% |
Market Drivers
7/31/2023 to 8/8/2026| Return | Correlation | |
|---|---|---|
| EPC | -23.3% | |
| Market (SPY) | 74.9% | 23.4% |
| Sector (XLP) | 21.1% | 44.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| EPC Return | 34% | -14% | -3% | -7% | -48% | 67% | -10% |
| Peers Return | 29% | -9% | 25% | -38% | -23% | 2% | -28% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 13% | 105% |
Monthly Win Rates [3] | |||||||
| EPC Win Rate | 42% | 50% | 33% | 58% | 8% | 75% | |
| Peers Win Rate | 60% | 38% | 53% | 35% | 30% | 55% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| EPC Max Drawdown | -26% | -37% | -24% | -18% | -53% | -33% | |
| Peers Max Drawdown | -26% | -44% | -40% | -53% | -46% | -37% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: ELF, IPAR, USNA, NUS, MED. See EPC Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 8/7/2026 (YTD)
How Low Can It Go
| Event | EPC | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -22.0% | -18.8% |
| % Gain to Breakeven | 28.2% | 23.1% |
| Time to Breakeven | 398 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -14.5% | -9.5% |
| % Gain to Breakeven | 16.9% | 10.5% |
| Time to Breakeven | 91 days | 24 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -28.9% | -24.5% |
| % Gain to Breakeven | 40.7% | 32.4% |
| Time to Breakeven | 326 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -37.0% | -33.7% |
| % Gain to Breakeven | 58.8% | 50.9% |
| Time to Breakeven | 234 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -20.9% | -19.2% |
| % Gain to Breakeven | 26.5% | 23.8% |
| Time to Breakeven | 50 days | 105 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -19.2% | -17.9% |
| % Gain to Breakeven | 23.8% | 21.8% |
| Time to Breakeven | 298 days | 123 days |
In The Past
Edgewell Personal Care's stock fell -22.0% during the 2025 US Tariff Shock. Such a loss loss requires a 28.2% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | EPC | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -22.0% | -18.8% |
| % Gain to Breakeven | 28.2% | 23.1% |
| Time to Breakeven | 398 days | 79 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -28.9% | -24.5% |
| % Gain to Breakeven | 40.7% | 32.4% |
| Time to Breakeven | 326 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -37.0% | -33.7% |
| % Gain to Breakeven | 58.8% | 50.9% |
| Time to Breakeven | 234 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -20.9% | -19.2% |
| % Gain to Breakeven | 26.5% | 23.8% |
| Time to Breakeven | 50 days | 105 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -72.9% | -53.4% |
| % Gain to Breakeven | 268.6% | 114.4% |
| Time to Breakeven | 1842 days | 1085 days |
In The Past
Edgewell Personal Care's stock fell -22.0% during the 2025 US Tariff Shock. Such a loss loss requires a 28.2% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Edgewell Personal Care (EPC)
Edgewell Personal Care (EPC) is a global consumer products company specializing in the manufacturing and marketing of a wide range of personal care items. With a heritage dating back to 1772, Edgewell operates through three primary segments: Wet Shave, Sun and Skin Care, and Feminine Care, catering to everyday personal hygiene and grooming needs of consumers worldwide.
The Wet Shave segment is a core part of Edgewell's business, offering razor systems (handles and refillable blades) and disposable razors for both men and women under prominent brands such as Schick, Wilkinson Sword, Edge, and Skintimate. Its Sun and Skin Care segment provides extensive sun protection products, including lotions, sprays, and after-sun treatments, through popular brands like Banana Boat and Hawaiian Tropic. This segment also includes hygiene products like Wet Ones antibacterial wipes and sanitizers, along with specialized men's skincare and grooming brands such as Bulldog, Jack Black, and Cremo.
Edgewell's Feminine Care segment addresses essential needs with a portfolio of tampons under brands like Playtex and o.b., and pads and liners from Stayfree and Carefree. Overall, Edgewell Personal Care serves a broad global market, providing essential products for men, women, and children across various demographics, making it a key player in the personal care industry.
AI Analysis | Feedback
A focused Procter & Gamble in shaving, sun care, and feminine hygiene.
The Kimberly-Clark of the shaving aisle, also providing sun care and feminine hygiene products.
AI Analysis | Feedback
- Wet Shave Products: Includes razor systems (handles and refillable blades) and disposable razors for men and women under brands like Schick, Wilkinson Sword, Edge, and Skintimate.
- Sun and Skin Care Products: Comprises sun protection, tanning, and after-sun products (Banana Boat, Hawaiian Tropic), antibacterial wipes and hand sanitizers (Wet Ones), and men's skincare/grooming products (Bulldog, Jack Black, Cremo).
- Feminine Care Products: Offers tampons under brands such as Playtex and o.b., and markets pads and liners primarily under the Stayfree and Carefree brands.
AI Analysis | Feedback
Edgewell Personal Care (EPC) sells its branded personal care products primarily to other companies, specifically major retailers and e-commerce platforms, who then sell these products to individual consumers.
The major customers for Edgewell Personal Care include:
- Walmart Inc. (WMT)
- Amazon.com, Inc. (AMZN)
- CVS Health Corporation (CVS)
- The Kroger Co. (KR)
- Target Corporation (TGT)
- Walgreens Boots Alliance, Inc. (WBA)
AI Analysis | Feedback
AI Analysis | Feedback
Rod R. Little, President and Chief Executive Officer
Rod R. Little was appointed President and Chief Executive Officer of Edgewell Personal Care effective March 1, 2019, having previously served as the company's Chief Financial Officer since March 2018. Prior to joining Edgewell, he held the position of CFO at HSN Inc. and Elizabeth Arden Inc. At HSN Inc., he was responsible for developing a revised financial plan focused on cost reduction and shifting investment priorities to drive long-term growth, along with leading a strategy renewal supported by investments in digital, e-commerce, and supply chain. During his tenure as CFO at Elizabeth Arden, he played a crucial role in a turnaround that successfully restored revenue growth and profitability. Earlier in his career, he served as CFO for Procter & Gamble's global salon professional division.
Francesca Weissman, Chief Financial Officer
Francesca Weissman became Chief Financial Officer of Edgewell Personal Care effective December 1, 2024. She joined Edgewell in 2019 and brings over 25 years of extensive finance experience, encompassing finance, accounting, mergers and acquisitions, and corporate strategy. Before her role at Edgewell, Ms. Weissman served as CFO of Party City Retail Group, Senior Vice President of Finance and Strategy at Ahold USA, and CFO of Stop & Shop. She also held various executive finance positions at Heineken USA for over 12 years and began her career at Ernst & Young.
LaTanya Langley, Chief People and Legal Officer
LaTanya Langley serves as Edgewell Personal Care's Chief People and Legal Officer and Corporate Secretary, where she is responsible for leading the Human Resources and Legal functions.
Jessica Spence, President of North America
Jessica Spence joined Edgewell Personal Care in 2024 as the President of North America. She contributes over two decades of experience in Marketing, Sales, Advertising, eCommerce, and Operations, and is responsible for leading the company's North America commercial business.
Paul Hibbert, Chief Supply Chain Officer
Paul Hibbert holds the position of Chief Supply Chain Officer at Edgewell Personal Care.
AI Analysis | Feedback
- Intense Competition and Market Share Erosion: Edgewell operates in highly competitive personal care markets, particularly in its Wet Shave segment, where it contends with established players like Procter & Gamble (Gillette) and agile direct-to-consumer (DTC) brands such as Harry's and Dollar Shave Club. This intense competition leads to pricing pressure, increased promotional activities, and a struggle to maintain or grow market share across its product lines, including sun and skin care. The company's efforts to differentiate through innovation and acquisitions, like Billie, are ongoing in this challenging environment.
- High Financial Leverage and Limited Flexibility: The company carries a significant debt load, reflected in an elevated debt-to-equity ratio and adjusted leverage. S&P Global Ratings revised Edgewell's outlook to negative, citing expectations that its adjusted leverage would remain high, exceeding the downgrade trigger. This high leverage limits Edgewell's financial flexibility, potentially hindering its ability to invest in growth initiatives, pursue strategic acquisitions, or effectively respond to unforeseen market downturns.
- North American Market Underperformance and Macroeconomic Pressures: Edgewell has experienced persistent organic sales declines in its crucial North American market across various segments, including Wet Shave and Sun Care. This underperformance is compounded by broader macroeconomic headwinds such as inflation, tariffs, and cautious consumer spending, which collectively put pressure on gross margins and overall profitability.
AI Analysis | Feedback
The following are clear emerging threats to Edgewell Personal Care:
- The continued rise and market share capture of Direct-to-Consumer (DTC) subscription models in the shaving industry. Companies like Dollar Shave Club and Harry's have disrupted the traditional retail model for razors and blades by offering competitive pricing and convenience through online subscriptions, directly challenging Edgewell's established brands like Schick and Wilkinson Sword.
- The increasing adoption and preference for sustainable and reusable feminine hygiene products. Alternatives such as menstrual cups, period underwear, and reusable pads directly compete with Edgewell's disposable tampons and pads (Playtex, o.b., Stayfree, Carefree), appealing to consumers seeking environmental benefits, long-term cost savings, and alternative comfort.
AI Analysis | Feedback
Edgewell Personal Care (EPC) operates within several substantial addressable markets for its main product categories:
- Wet Shave Products (Schick, Wilkinson Sword, Edge, Skintimate, Shave Guard, Personna):
- The global wet shave market was valued at approximately USD 19,177.8 million in 2024.
- In the U.S., the wet shave market recorded revenues of USD 3,286.9 million in 2024.
- Sun Care Products (Banana Boat, Hawaiian Tropic):
- The global sun care products market size reached USD 14.0 billion in 2024.
- The U.S. sun care market was valued at USD 15.55 billion in 2024.
- Men's Skincare Products (Bulldog, Jack Black, Cremo):
- The global men's skincare products market was estimated at USD 19.6 billion in 2024.
- The U.S. men's skincare products market was worth over USD 3.4 billion in 2024.
- Feminine Care Products (Playtex, o.b., Stayfree, Carefree):
- The global feminine hygiene products market size was valued at USD 46.85 billion in 2024.
- The U.S. feminine hygiene products market size was valued at USD 15.56 billion in 2024.
- Hand Sanitizers and Wipes (Wet Ones):
- The global hand sanitizer market size was valued at USD 6.96 billion in 2024.
- The U.S. hand sanitizer market was valued at USD 1.9 billion in 2025.
- The global wipes market size was valued at USD 25.1 billion in 2025.
AI Analysis | Feedback
Edgewell Personal Care (EPC) is expected to drive future revenue growth over the next 2-3 years through several key strategies:
- International Market Expansion and Performance: The company anticipates continued strong performance and mid-single-digit organic net sales growth in its international markets, particularly in regions like Japan and Germany, where it has seen notable market share gains. This growth is underpinned by both price and volume gains.
- Strategic Pricing and Revenue Management: Edgewell Personal Care plans to continue leveraging pricing strategies and effective revenue management to contribute to organic net sales growth and expand gross margins.
- Innovation and New Product Launches: The company is committed to consumer-led, locally designed innovation across its portfolio. This includes recent examples such as the launch of Progista in premium skincare in Japan and the expansion of the Cremo brand in the United States and Europe, alongside an overall multiyear innovation roadmap. Increased advertising investment is planned to support these new product introductions.
- Supply Chain Optimization and Productivity Initiatives: Edgewell expects to realize significant productivity savings through ongoing operational efficiency programs and supply chain optimization. These initiatives aim to reduce complexity, improve customer service, shorten lead times, and lower inventory, thereby supporting gross margin expansion and enabling reinvestment into core brands.
- Increased Brand Investment and Marketing: Edgewell plans to increase its advertising and sales promotion (A&P) investments to support its U.S. transformation efforts and to fuel key international brands. This strategic investment is aimed at driving increased household penetration and strengthening its leadership in competitive markets.
AI Analysis | Feedback
Share Repurchases
- Edgewell Personal Care completed share repurchases of $90.2 million in fiscal year 2025.
- The company repurchased shares worth $24.5 million during the third fiscal quarter of 2025.
- A new share repurchase authorization for up to $100 million was issued on November 13, 2025, superseding a prior authorization.
Outbound Investments
- On November 29, 2021, Edgewell Personal Care acquired Billie, Inc., a high-quality shaving and premium body care brand, strengthening its women's Wet Shave and grooming portfolio.
- The company entered into a definitive agreement on November 12, 2025, to sell its Feminine Care business to Essity for $340 million, with the transaction closing in the first quarter of calendar 2026.
- Proceeds from the Feminine Care business sale are intended to strengthen the balance sheet, support debt reduction, and enable reinvestment in core brands and innovation.
Capital Expenditures
- Capital expenditures for Edgewell Personal Care peaked at $77 million in fiscal year 2025.
- Capital expenditures were $56.5 million in fiscal year 2024 and $49.5 million in fiscal year 2023.
- For fiscal year 2026, capital expenditures are expected to be approximately 3.0% to 3.5% of net sales, with a primary focus on investing in a new, highly automated manufacturing plant to enhance the Wet Shave business.
Latest Trefis Analyses
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 21.93 |
| Mkt Cap | 0.8 |
| Rev LTM | 1,471 |
| Op Inc LTM | 106 |
| FCF LTM | 47 |
| FCF 3Y Avg | 74 |
| CFO LTM | 99 |
| CFO 3Y Avg | 129 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 4.3% |
| Rev Chg 3Y Avg | -0.6% |
| Rev Chg Q | 1.0% |
| QoQ Delta Rev Chg LTM | 0.3% |
| Op Inc Chg LTM | -11.0% |
| Op Inc Chg 3Y Avg | -10.3% |
| Op Mgn LTM | 5.7% |
| Op Mgn 3Y Avg | 7.9% |
| QoQ Delta Op Mgn LTM | -0.6% |
| CFO/Rev LTM | 5.3% |
| CFO/Rev 3Y Avg | 6.6% |
| FCF/Rev LTM | 2.6% |
| FCF/Rev 3Y Avg | 4.0% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 0.8 |
| P/S | 0.5 |
| P/Op Inc | 7.9 |
| P/EBIT | 10.7 |
| P/E | 14.2 |
| P/CFO | 15.7 |
| Total Yield | 2.0% |
| Dividend Yield | 1.1% |
| FCF Yield 3Y Avg | 5.3% |
| D/E | 0.2 |
| Net D/E | 0.0 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 8.1% |
| 3M Rtn | 15.7% |
| 6M Rtn | 15.5% |
| 12M Rtn | -2.5% |
| 3Y Rtn | -50.3% |
| 1M Excs Rtn | 5.3% |
| 3M Excs Rtn | 10.0% |
| 6M Excs Rtn | 6.1% |
| 12M Excs Rtn | -29.0% |
| 3Y Excs Rtn | -123.0% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Wet Shave | 1,219 | 1,229 | 1,231 | 1,242 | 1,216 |
| Sun and Skin Care | 743 | 741 | 706 | 638 | 585 |
| Feminine Care | 262 | 284 | 315 | 291 | 286 |
| Total | 2,224 | 2,254 | 2,252 | 2,172 | 2,087 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Wet Shave | 204 | 158 | 174 | 222 | 206 |
| Sun and Skin Care | 131 | 137 | 109 | 99 | 69 |
| Feminine Care | 29 | 50 | 32 | 38 | 52 |
| Legal matters | -4 | 6 | 8 | 0 | |
| Sun Care reformulation costs | -4 | -2 | -5 | -1 | |
| Other project and related costs | -5 | -0 | 0 | ||
| Acquisition and integration costs | -6 | -8 | -10 | -8 | -40 |
| Wet Ones manufacturing plant fire | -12 | 0 | |||
| Amortization of intangibles | -31 | -31 | -29 | -22 | -17 |
| Restructuring and related charges | -36 | -17 | -16 | -30 | -38 |
| General corporate expenses | -66 | -69 | -54 | -56 | -55 |
| Stock keeping unit (SKU) rationalization | 2 | -22 | 0 | ||
| Value-added tax (VAT) settlement costs | -3 | 0 | |||
| All Other | 0 | 3 | |||
| COVID-19 expense | -4 | ||||
| Feminine and Infant Care evaluation costs | -0 | ||||
| Total | 199 | 227 | 182 | 240 | 176 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Goodwill and other intangible assets, net | 2,287 | 2,305 | 2,319 | 2,069 | 2,088 |
| Wet Shave | 724 | 724 | 751 | 714 | 710 |
| Sun and Skin Care | 314 | 316 | 277 | 256 | 212 |
| Corporate | 229 | 232 | 207 | 498 | 385 |
| Feminine Care | 176 | 163 | 159 | 137 | 146 |
| Total | 3,731 | 3,741 | 3,713 | 3,675 | 3,541 |
Price Behavior
| Market Price | $28.38 | |
| Market Cap ($ Bil) | 1.3 | |
| First Trading Date | 03/27/2000 | |
| Distance from 52W High | -4.3% | |
| 50 Days | 200 Days | |
| DMA Price | $25.14 | $20.79 |
| DMA Trend | up | up |
| Distance from DMA | 12.9% | 36.5% |
| 3M | 1YR | |
| Volatility | 57.8% | 42.5% |
| Downside Capture | -114.82 | 9.27 |
| Upside Capture | 36.72 | 39.42 |
| Correlation (SPY) | -15.5% | 5.7% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.67 | -0.97 | -0.77 | -0.07 | 0.23 | 0.53 |
| Up Beta | -3.85 | -1.95 | -1.25 | 0.18 | 0.42 | 0.71 |
| Down Beta | -0.16 | -1.73 | -1.63 | -0.73 | -0.29 | 0.26 |
| Up Capture | 20% | 120% | 19% | 42% | 30% | 16% |
| Bmk +ve Days | 11 | 22 | 35 | 67 | 138 | 427 |
| Stock +ve Days | 10 | 25 | 33 | 69 | 127 | 369 |
| Down Capture | 1% | -211% | -92% | -49% | 46% | 88% |
| Bmk -ve Days | 11 | 21 | 28 | 59 | 114 | 326 |
| Stock -ve Days | 12 | 18 | 30 | 57 | 124 | 378 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with EPC | |
|---|---|---|---|---|
| EPC | 34.7% | 42.4% | 0.81 | - |
| Sector ETF (XLP) | 6.5% | 14.1% | 0.21 | 46.3% |
| Equity (SPY) | 23.3% | 12.8% | 1.36 | 5.5% |
| Gold (GLD) | 28.5% | 28.4% | 0.87 | 0.6% |
| Commodities (DBC) | 32.9% | 19.8% | 1.32 | -24.0% |
| Real Estate (VNQ) | 14.2% | 13.8% | 0.72 | 44.4% |
| Bitcoin (BTCUSD) | -43.7% | 43.0% | -1.21 | -0.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with EPC | |
|---|---|---|---|---|
| EPC | -5.4% | 34.2% | -0.10 | - |
| Sector ETF (XLP) | 6.2% | 13.6% | 0.24 | 43.4% |
| Equity (SPY) | 13.5% | 17.2% | 0.61 | 28.4% |
| Gold (GLD) | 18.6% | 18.6% | 0.81 | 1.8% |
| Commodities (DBC) | 8.2% | 19.6% | 0.31 | -3.0% |
| Real Estate (VNQ) | 2.3% | 18.9% | 0.02 | 38.1% |
| Bitcoin (BTCUSD) | 9.0% | 53.0% | 0.36 | 9.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with EPC | |
|---|---|---|---|---|
| EPC | -9.3% | 37.5% | -0.15 | - |
| Sector ETF (XLP) | 7.3% | 14.8% | 0.36 | 46.6% |
| Equity (SPY) | 15.4% | 17.9% | 0.73 | 37.9% |
| Gold (GLD) | 12.1% | 16.2% | 0.61 | 0.3% |
| Commodities (DBC) | 7.4% | 18.0% | 0.33 | 6.2% |
| Real Estate (VNQ) | 4.8% | 20.7% | 0.20 | 40.3% |
| Bitcoin (BTCUSD) | 58.4% | 66.2% | 0.98 | 8.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Updated 8/9/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 8/5/2026 | 2.3% | ||
| 5/6/2026 | -1.9% | -15.6% | -13.4% |
| 2/9/2026 | -4.6% | 5.5% | 0.1% |
| 11/13/2025 | -2.7% | -7.8% | -6.6% |
| 8/5/2025 | -18.8% | -11.8% | -5.0% |
| 5/7/2025 | -10.0% | -5.3% | -10.9% |
| 2/10/2025 | -9.5% | -5.8% | 0.9% |
| 11/7/2024 | 0.2% | -4.6% | 1.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 14 | 11 | 11 |
| # Negative | 11 | 13 | 13 |
| Median Positive | 2.9% | 5.0% | 3.2% |
| Median Negative | -4.6% | -5.3% | -3.5% |
| Max Positive | 9.1% | 9.4% | 13.6% |
| Max Negative | -18.8% | -16.9% | -15.0% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 8/5/2026 | 2.3% | ||
| 5/6/2026 | -1.9% | -15.6% | -13.4% |
| 2/9/2026 | -4.6% | 5.5% | 0.1% |
| 11/13/2025 | -2.7% | -7.8% | -6.6% |
| 8/5/2025 | -18.8% | -11.8% | -5.0% |
| 5/7/2025 | -10.0% | -5.3% | -10.9% |
| 2/10/2025 | -9.5% | -5.8% | 0.9% |
| 11/7/2024 | 0.2% | -4.6% | 1.5% |
| 8/6/2024 | 1.0% | -3.2% | 6.6% |
| 5/8/2024 | 3.2% | 9.4% | 4.2% |
| 2/7/2024 | 1.6% | 3.7% | 3.2% |
| 11/9/2023 | -1.7% | 2.9% | -0.2% |
| 8/3/2023 | 3.4% | -1.8% | -3.5% |
| 5/9/2023 | 5.5% | 2.0% | -1.5% |
| 2/8/2023 | 3.4% | 3.9% | -1.2% |
| 11/10/2022 | 1.4% | 1.4% | 3.9% |
| 8/4/2022 | 2.5% | 5.0% | -2.3% |
| 5/10/2022 | -13.7% | -6.4% | -8.4% |
| 2/8/2022 | -13.2% | -16.9% | -15.0% |
| 11/12/2021 | -0.4% | -0.5% | 2.5% |
| 8/5/2021 | 4.6% | 9.4% | 2.0% |
| 5/6/2021 | 9.1% | 6.5% | 13.6% |
| 2/9/2021 | 0.2% | -2.9% | -0.2% |
| 11/12/2020 | 4.6% | 6.8% | 12.6% |
| 8/4/2020 | -2.6% | -0.8% | -1.2% |
| SUMMARY STATS | |||
| # Positive | 14 | 11 | 11 |
| # Negative | 11 | 13 | 13 |
| Median Positive | 2.9% | 5.0% | 3.2% |
| Median Negative | -4.6% | -5.3% | -3.5% |
| Max Positive | 9.1% | 9.4% | 13.6% |
| Max Negative | -18.8% | -16.9% | -15.0% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/05/2026 | 10-Q |
| 03/31/2026 | 05/06/2026 | 10-Q |
| 12/31/2025 | 02/09/2026 | 10-Q |
| 09/30/2025 | 11/18/2025 | 10-K |
| 06/30/2025 | 08/05/2025 | 10-Q |
| 03/31/2025 | 05/07/2025 | 10-Q |
| 12/31/2024 | 02/10/2025 | 10-Q |
| 09/30/2024 | 11/14/2024 | 10-K |
| 06/30/2024 | 08/06/2024 | 10-Q |
| 03/31/2024 | 05/08/2024 | 10-Q |
| 12/31/2023 | 02/07/2024 | 10-Q |
| 09/30/2023 | 11/28/2023 | 10-K |
| 06/30/2023 | 08/03/2023 | 10-Q |
| 03/31/2023 | 05/09/2023 | 10-Q |
| 12/31/2022 | 02/08/2023 | 10-Q |
| 09/30/2022 | 11/16/2022 | 10-K |
| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/05/2026 | 10-Q |
| 03/31/2026 | 05/06/2026 | 10-Q |
| 12/31/2025 | 02/09/2026 | 10-Q |
| 09/30/2025 | 11/18/2025 | 10-K |
| 06/30/2025 | 08/05/2025 | 10-Q |
| 03/31/2025 | 05/07/2025 | 10-Q |
| 12/31/2024 | 02/10/2025 | 10-Q |
| 09/30/2024 | 11/14/2024 | 10-K |
| 06/30/2024 | 08/06/2024 | 10-Q |
| 03/31/2024 | 05/08/2024 | 10-Q |
| 12/31/2023 | 02/07/2024 | 10-Q |
| 09/30/2023 | 11/28/2023 | 10-K |
| 06/30/2023 | 08/03/2023 | 10-Q |
| 03/31/2023 | 05/09/2023 | 10-Q |
| 12/31/2022 | 02/08/2023 | 10-Q |
| 09/30/2022 | 11/16/2022 | 10-K |
| 06/30/2022 | 08/04/2022 | 10-Q |
| 03/31/2022 | 05/10/2022 | 10-Q |
| 12/31/2021 | 02/08/2022 | 10-Q |
| 09/30/2021 | 11/19/2021 | 10-K |
| 06/30/2021 | 08/05/2021 | 10-Q |
| 03/31/2021 | 05/06/2021 | 10-Q |
| 12/31/2020 | 02/09/2021 | 10-Q |
| 09/30/2020 | 11/20/2020 | 10-K |
| 06/30/2020 | 08/04/2020 | 10-Q |
| 03/31/2020 | 05/07/2020 | 10-Q |
| 12/31/2019 | 02/10/2020 | 10-Q |
| 09/30/2019 | 11/26/2019 | 10-K |
Recent Forward Guidance
Updated 8/6/2026Latest: Q3 2026 Earnings Reported 8/5/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Reported Net Sales Growth | 1.3% | 1.55% | 1.8% | -0.8% | Lowered | Guidance: 2.3% for 2026 | |
| 2026 Organic Net Sales Growth | 0.0% | 0.25% | 0.5% | -0.2% | Lowered | Guidance: 0.5% for 2026 | |
| 2026 GAAP EPS | 0 | 0.1 | 0.2 | -50.0% | Lowered | Guidance: 0.2 for 2026 | |
| 2026 Adjusted EPS | 1.8 | 1.9 | 2 | 0.0% | Affirmed | Guidance: 1.9 for 2026 | |
| 2026 Adjusted EBITDA | 250.00 Mil | 255.00 Mil | 260.00 Mil | 0.0% | Affirmed | Guidance: 255.00 Mil for 2026 | |
| 2026 Adjusted Free Cash Flow | 80.00 Mil | 95.00 Mil | 110.00 Mil | 0.0% | Affirmed | Guidance: 95.00 Mil for 2026 | |
Prior: Q2 2026 Earnings Reported 5/6/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Reported Net Sales Growth | 0.8% | 2.3% | 3.8% | 0.3% | Raised | Guidance: 2.0% for 2026 | |
| 2026 Organic Net Sales Growth | -1.0% | 0.5% | 2.0% | 0.0% | Affirmed | Guidance: 0.5% for 2026 | |
| 2026 GAAP EPS | 0 | 0.2 | 0.4 | -73.3% | Lowered | Guidance: 0.75 for 2026 | |
| 2026 Adjusted EPS | 1.7 | 1.9 | 2.1 | 0.0% | Affirmed | Guidance: 1.9 for 2026 | |
| 2026 Adjusted EBITDA | 245.00 Mil | 255.00 Mil | 265.00 Mil | 0.0% | Affirmed | Guidance: 255.00 Mil for 2026 | |
| 2026 Adjusted Free Cash Flow | 80.00 Mil | 95.00 Mil | 110.00 Mil | 0.0% | Affirmed | Guidance: 95.00 Mil for 2026 | |
Q1 2026 Earnings Reported 2/9/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Reported Net Sales Growth | 0.5% | 2.0% | 3.5% | 0 | Affirmed | Guidance: 2.0% for 2026 | |
| 2026 Organic Net Sales Growth | -1.0% | 0.5% | 2.0% | 0 | Affirmed | Guidance: 0.5% for 2026 | |
| 2026 GAAP EPS | 0.55 | 0.75 | 0.95 | -42.3% | Lowered | Guidance: 1.3 for 2026 | |
| 2026 Adjusted EPS | 1.7 | 1.9 | 2.1 | -19.1% | Lowered | Guidance: 2.35 for 2026 | |
| 2026 Adjusted EBITDA | 245.00 Mil | 255.00 Mil | 265.00 Mil | -15.0% | Lowered | Guidance: 300.00 Mil for 2026 | |
| 2026 Adjusted Free Cash Flow | 80.00 Mil | 95.00 Mil | 110.00 Mil | -26.9% | Lowered | Guidance: 130.00 Mil for 2026 | |
Q4 2025 Earnings Reported 11/13/2025
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Revenue Growth | 0.5% | 2.0% | |||||
| 2026 Organic Net Sales Growth | -1.0% | 0.5% | 2.0% | 1.8% | Higher New | Guidance: -1.3% for 2025 | |
| 2026 GAAP EPS | 1.1 | 1.3 | 1.5 | -24.9% | Lower New | Guidance: 1.73 for 2025 | |
| 2026 Adjusted EPS | 2.15 | 2.35 | 2.55 | -11.3% | Lower New | Guidance: 2.65 for 2025 | |
| 2026 Adjusted EBITDA | 290.00 Mil | 300.00 Mil | 310.00 Mil | -3.8% | Lower New | Guidance: 312.00 Mil for 2025 | |
| 2026 Adjusted Effective Tax Rate | 21.0% | 21.5% | 22.0% | 5.0% | Higher New | Guidance: 16.5% for 2025 | |
| 2026 Capital Expenditures | 0.03 | 0.03 | 0.04 | 0.5% | Higher New | Guidance: 0.03 for 2025 | |
| 2026 Free Cash Flow | 115.00 Mil | 130.00 Mil | 145.00 Mil | 62.5% | Higher New | Guidance: 80.00 Mil for 2025 | |
Insider Activity
Updated 4/26/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dunham, John M | Chief Accounting Officer | Direct | Sell | 11202025 | 17.21 | 333 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dunham, John M | Chief Accounting Officer | Direct | Sell | 11202025 | 17.21 | 333 | Form |
Industry Resources
| Consumer Staples Resources |
| FoodNavigator |
| Consumer Goods Technology (CGT) |
| Beverage Digest |
| Household Products Resources |
| Happi (Household and Personal Products Industry) |
| Nonwovens Industry |
| Consumer Reports - Household Products |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.